Changes in gene expression during G-CSF-induced emergency granulopoiesis in humans

Journal of Immunology

Volumn 197, Issue 5, 2016, Pages 1989-1999

  Pedersen, Corinna C ^a   Borup, Rehannah ^a   Fischer Nielsen, Anne ^a   Mora Jensen, Helena ^a   Fossum, Anna ^b   Cowland, Jack B ^a   Borregaard, Niels ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; PEPTIDES AND PROTEINS; PROTEIN CAP 18; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL MATURATION; CONTROLLED STUDY; EMERGENCY GRANULOPOIESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GRANULOPOIESIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MICROARRAY ANALYSIS; NEUTROPHIL PRECURSOR; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; CELL MOTION; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LEUKOPOIESIS; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; CELL MOVEMENT; CYTOKINES; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEALTHY VOLUNTEERS; HUMANS; LEUKOPOIESIS; MICROARRAY ANALYSIS; NEUTROPHILS; RECOMBINANT PROTEINS;

EID: 84983739537     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502690     Document Type: Article

References (49)

1. Wang, J., and H. Arase. 2014. Regulation of immune responses by neutrophils. Ann. N. Y. Acad. Sci. 1319: 66-81.
2. Dinauer, M. C., J. A. Lekstrom-Himes, and D. C. Dale. 2000. Inherited neutrophil disorders: molecular basis and new therapies. Hematology Am. Soc. Hematol. Educ. Program 2000: 303-318.
3. Lekstrom-Himes, J. A., and J. I. Gallin. 2000. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 343: 1703-1714.
4. Ye, Y., G. Carlsson, J. M. Karlsson-Sjöberg, N. Borregaard, T. U. Modéer, M. L. Andersson, and K. L. Putsep. 2015. The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective study. Sci. Rep. 5: 11685.
5. Summers, C., S. M. Rankin, A. M. Condliffe, N. Singh, A. M. Peters, and E. R. Chilvers. 2010. Neutrophil kinetics in health and disease. Trends Immunol. 31: 318-324.
6. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012-2020.
7. Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13: 159-175.
8. Panopoulos, A. D., and S. S. Watowich. 2008. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine 42: 277-288.
9. Lieschke, G. J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan, and A. R. Dunn. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84: 1737-1746.
10. Betsuyaku, T., F. Liu, R. M. Senior, J. S. Haug, E. J. Brown, S. L. Jones, K. Matsushima, and D. C. Link. 1999. A functional granulocyte colonystimulating factor receptor is required for normal chemoattractant-induced neutrophil activation. J. Clin. Invest. 103: 825-832.
11. Nicola, N. A., D. Metcalf, M. Matsumoto, and G. R. Johnson. 1983. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: identification as granulocyte colony-stimulating factor. J. Biol. Chem. 258: 9017-9023.
12. Borregaard, N. 2010. Neutrophils, from marrow to microbes. Immunity 33: 657-670.
13. Liongue, C., C. Wright, A. P. Russell, and A. C. Ward. 2009. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int. J. Biochem. Cell Biol. 41: 2372-2375.
14. Metcalf, D. 1985. The granulocyte-macrophage colony stimulating factors. Cell 43: 5-6.
15. Liu, F., H. Y. Wu, R. Wesselschmidt, T. Kornaga, and D. C. Link. 1996. Impaired production and increased apoptosis of neutrophils in granulocyte colonystimulating factor receptor-deficient mice. Immunity 5: 491-501.
16. Nauseef, W. M., and N. Borregaard. 2014. Neutrophils at work. Nat. Immunol. 15: 602-611.
17. Manz, M. G., and S. Boettcher. 2014. Emergency granulopoiesis. Nat. Rev. Immunol. 14: 302-314.
18. Hirai, H., P. Zhang, T. Dayaram, C. J. Hetherington, S. Mizuno, J. Imanishi, K. Akashi, and D. G. Tenen. 2006. C/EBPbeta is required for 'emergency' granulopoiesis. Nat. Immunol. 7: 732-739.
19. Skokowa, J., D. Lan, B. K. Thakur, F. Wang, K. Gupta, G. Cario, A. M. Brechlin, A. Schambach, L. Hinrichsen, G. Meyer, et al. 2009. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat. Med. 15: 151-158.
20. Satake, S., H. Hirai, Y. Hayashi, N. Shime, A. Tamura, H. Yao, S. Yoshioka, Y. Miura, T. Inaba, N. Fujita, et al. 2012. C/EBPb is involved in the amplification of early granulocyte precursors during candidemia-induced emergency granulopoiesis. J. Immunol. 189: 4546-4555.
21. Zhang, H., H. Nguyen-Jackson, A. D. Panopoulos, H. S. Li, P. J. Murray, and S. S. Watowich. 2010. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116: 2462-2471.
22. Hirai, H., N. Kamio, G. Huang, A. Matsusue, S. Ogino, N. Kimura, S. Satake, E. Ashihara, J. Imanishi, D. G. Tenen, and T. Maekawa. 2013. Cyclic AMP responsive element binding proteins are involved in 'emergency' granulopoiesis through the upregulation of CCAAT/enhancer binding protein b. PLoS One 8: e54862.
23. Theilgaard-Mönch, K., L. C. Jacobsen, R. Borup, T. Rasmussen, M. D. Bjerregaard, F. C. Nielsen, J. B. Cowland, and N. Borregaard. 2005. The transcriptional program of terminal granulocytic differentiation. Blood 105: 1785-1796.
24. Bjerregaard, M. D., J. Jurlander, P. Klausen, N. Borregaard, and J. B. Cowland. 2003. The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow. Blood 101: 4322-4332.
25. Mora-Jensen, H., J. Jendholm, A. Fossum, B. Porse, N. Borregaard, and K. Theilgaard-Mönch. 2011. Technical advance: immunophenotypical characterization of human neutrophil differentiation. J. Leukoc. Biol. 90: 629-634.
26. Sørensen, O., J. B. Cowland, J. Askaa, and N. Borregaard. 1997. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J. Immunol. Methods 206: 53-59.
27. Emmertsen, F., A. Glenthøj, J. Sønderskov, P. Kampmann, H. Sengeløv, and N. Borregaard. 2014. ProHNPs are specific markers of normal myelopoiesis. Blood Cancer J. 4: e193.
28. Clemmensen, S. N., L. Udby, and N. Borregaard. 2014. Subcellular fractionation of human neutrophils and analysis of subcellular markers. Methods Mol. Biol. 1124: 53-76.
29. Rapin, N., F. O. Bagger, J. Jendholm, H. Mora-Jensen, A. Krogh, A. Kohlmann, C. Thiede, N. Borregaard, L. Bullinger, O. Winther, et al. 2014. Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients. Blood 123: 894-904.
30. Johnson, W. E., C. Li, and A. Rabinovic. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
31. Na, D., H. Son, and J. Gsponer. 2014. Categorizer: a tool to categorize genes into userdefined biological groups based on semantic similarity. BMC Genomics 15: 1091.
32. Binns, D., E. Dimmer, R. Huntley, D. Barrell, C. O'Donovan, and R. Apweiler. 2009. QuickGO: a web-based tool for Gene Ontology searching. Bioinformatics 25: 3045-3046.
33. Huang, W., B. T. Sherman, and R. A. Lempicki. 2009. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37: 1-13.
34. Huang, W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4: 44-57.
35. Terstappen, L. W., S. Buescher, M. Nguyen, and C. Reading. 1992. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 6: 1001-1010.
36. Futosi, K., S. Fodor, and A. Mócsai. 2013. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int. Immunopharmacol. 17: 638-650.
37. Lewis, S. M., D. F. Treacher, J. Edgeworth, G. Mahalingam, C. S. Brown, T. A. Mare, M. Stacey, R. Beale, and K. A. Brown. 2015. Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation. Clin. Exp. Immunol. 182: 184-194.
38. Eash, K. J., J. M. Means, D. W. White, and D. C. Link. 2009. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113: 4711-4719.
39. O'Mahony, D. S., U. Pham, R. Iyer, T. R. Hawn, and W. C. Liles. 2008. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int. J. Med. Sci. 5: 1-8.
40. Schuettpelz, L. G., J. N. Borgerding, M. J. Christopher, P. K. Gopalan, M. P. Romine, A. C. Herman, J. R. Woloszynek, A. M. Greenbaum, and D. C. Link. 2014. G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling. Leukemia 28: 1851-1860.
41. Chung, C. D., J. Liao, B. Liu, X. Rao, P. Jay, P. Berta, and K. Shuai. 1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278: 1803-1805.
42. Croker, B. A., D. Metcalf, L. Robb, W. Wei, S. Mifsud, L. DiRago, L. A. Cluse, K. D. Sutherland, L. Hartley, E. Williams, et al. 2004. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20: 153-165.
43. Highfill, S. L., P. C. Rodriguez, Q. Zhou, C. A. Goetz, B. H. Koehn, R. Veenstra, P. A. Taylor, A. Panoskaltsis-Mortari, J. S. Serody, D. H. Munn, et al. 2010. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747.
44. Lord, B. I., M. H. Bronchud, S. Owens, J. Chang, A. Howell, L. Souza, and T. M. Dexter. 1989. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. Sci. USA 86: 9499-9503.
45. Lord, B. I., G. Molineux, Z. Pojda, L. M. Souza, J. J. Mermod, and T. M. Dexter. 1991. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 77: 2154-2159.
46. Welte, K., M. A. Bonilla, A. P. Gillio, T. C. Boone, G. K. Potter, J. L. Gabrilove, M. A. Moore, R. J. O'Reilly, and L. M. Souza. 1987. Recombinant human granulocyte colony-stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates. J. Exp. Med. 165: 941-948.
47. Bronchud, M. H., M. R. Potter, G. Morgenstern, M. J. Blasco, J. H. Scarffe, N. Thatcher, D. Crowther, L. M. Souza, N. K. Alton, N. G. Testa, et al. 1988. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br. J. Cancer 58: 64-69.
48. de Haar, S. F., P. S. Hiemstra, M. T. van Steenbergen, V. Everts, and W. Beertsen. 2006. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect. Immun. 74: 5284-5291.
49. Grenda, D. S., M. Murakami, J. Ghatak, J. Xia, L. A. Boxer, D. Dale, M. C. Dinauer, and D. C. Link. 2007. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 110: 4179-4187.